BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
Uncategorized
Uncategorized
Ashvattha Therapeutics Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting and reprogramming activa…
Uncategorized
Addressing Demodex essential for ocular surface management
Until recently, Demodex blepharitis was often overlooked as a common cause of irritation, according to a panel discussion at OSN New York.Eric D. Donnenfeld, MD, Jai G. Parekh, MD, MBA, and Darrell E. White, MD, discussed the impact that Demodex mites …
Uncategorized
Addressing Demodex essential for ocular surface management
Until recently, Demodex blepharitis was often overlooked as a common cause of irritation, according to a panel discussion at OSN New York.Eric D. Donnenfeld, MD, Jai G. Parekh, MD, MBA, and Darrell E. White, MD, discussed the impact that Demodex mites …
Uncategorized
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
BARCELONA–(BUSINESS WIRE)–SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the Part B dose-expansion por…
Uncategorized
Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base
PARIS–(BUSINESS WIRE)–Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth equity firm focused on enabling technologies shaping …